Severe Acute Pain (DBCOND0021329)
Identifiers
- Synonyms
- Severe Pain, Acute / Acute Severe Pain / Severe Acute pain / Acute, severe Pain
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Celecoxib An NSAID used to treat osteoarthritis, rheumatoid arthritis, acute pain, menstrual symptoms, and to reduce polyps is familial adenomatous polyposis.- Prostaglandin G/H synthase 2target
- 3-phosphoinositide-dependent protein kinase 1target
- Cytochrome P450 2C9enzyme
- Cytochrome P450 2D6enzyme
- ATP-binding cassette sub-family C member 4transporter
- Cytochrome P450 3A4enzyme
- Cytochrome P450 2C8enzyme
- Carbonic anhydrase 2target
- Carbonic anhydrase 3target
- Bile salt export pumptransporter
- Cadherin-11target
- ATP-dependent translocase ABCB1transporter
- Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
- Prostaglandin G/H synthase 2enzyme
- Sialidase-1target
- Signal transducer and activator of transcription 3target
Ketorolac An NSAID used to treat moderate to severe pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders, and headaches.Oliceridine A biased opioid agonist indicated for the management of severe acute pain in adult patients. Through preferential activation of G-protein-coupled signalling pathways, oliceridine provides analgesic effect with a comparable or improved safety profile over conventional opioid agonists.- Mu-type opioid receptortarget
- Cytochrome P450 3A4enzyme
- Cytochrome P450 2D6enzyme
- Cytochrome P450 2C9enzyme
- Cytochrome P450 2C19enzyme
Oxycodone An opioid used in the management of moderate to severe pain.- Mu-type opioid receptortarget
- Kappa-type opioid receptortarget
- Delta-type opioid receptortarget
- Cytochrome P450 2D6enzyme
- Cytochrome P450 3A4enzyme
- Cytochrome P450 3A5enzyme
- Albumincarrier
- alpha1-acid glycoproteincarrier
Sufentanil An opioid used to induce and maintain anesthesia, to act as an analgesic in labor and delivery, and to treat severe, acute pain.- Mu-type opioid receptortarget
- Delta-type opioid receptortarget
- Kappa-type opioid receptortarget
- Cytochrome P450 3A4enzyme
Tapentadol An opioid used to manage severe pain that has not responded to non-opioid medications, and for which opioid analgesic therapy is appropriate.- Mu-type opioid receptortarget
- Kappa-type opioid receptortarget
- Delta-type opioid receptortarget
- Sodium-dependent noradrenaline transportertarget
- UDP-glucuronosyltransferase 1A9enzyme
- UDP-glucuronosyltransferase 2B7enzyme
- Cytochrome P450 2D6enzyme
- Cytochrome P450 2C9enzyme
- Cytochrome P450 2C19enzyme
- Sodium-dependent serotonin transportertarget
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT01892709 Titration of Intravenous Hydromorphone treatment 4 completed